- James Bernard
James Bernard
James is a commercially driven and results orientated business leader and strategies who offers over 28 years executive level experience within the research/life science industry. He was an integral part of the start up and ongoing executive management of the Serotec group of companies, managing the end to end process over a 23 years history from start up through to its eventual sale for £20m. For those years he had P&L accountability for a Euro 22.million turnover operation and expanded the business through setting up sister companies across Europe and North America. Through this experience, he has amassed detailed understanding of the political ,regulatory and competitor landscape and has utilised this information to design and deliver effective commercial strategies.
He is the CEO of a private consultancy company Oxford Bioconcepts Limited, and is a Director and sits on the Board of Oxford Expression Technologies Limited (www.oetltd.com) and Axicon Limited (www.axicon.com)
To email James - jamesb@2bscientific.com
